Company intelligence / Profile preview

BioCurate

Melbourne / Parkville, Victoria, Australiabiocurate.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

BioCurate specializes in identifying promising biomedical research from academia and managing its translation into high-quality preclinical drug candidates. The company operates at the critical early phases of therapeutic development, providing expertise to bridge the gap between academic discovery and commercial investment. No clinical results are published as BioCurate focuses on preclinical stages.

Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

NLC Healthtech Venture Builder, Netherlands—strategic alliance for commercialization of new therapiesExtensive collaborations with University of Melbourne and Monash University researchers

Beyond the preview

Go deeper on BioCurate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioCurate.

Explore the full profile